I think these results are pleasantly good imo. Most analyst were predicting a much larger drop off in revenue for this FY as most assumed covid was going to be eradicated once the vaccines were released.
Either way, through a longer term lens, the number of trained clinicians who have now heard of and used airvo 2 and optiflow systems have increased enormously around the world.
Ann: Fisher & Paykel Healthcare provides FY22 trading update, page-3
Add FPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.26 |
Change
0.060(0.22%) |
Mkt cap ! $15.91B | |||
| Open | High | Low | Value | Volume |
| $27.28 | $27.48 | $27.08 | $4.602M | 168.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 909 | $27.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.27 | 4567 | 3 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$27.22 |
Change
0.060 ( 0.05 %) |
||||
| Open | High | Low | Volume | ||
| $27.41 | $27.47 | $27.07 | 504072 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| FPH (ASX) Chart |